Skip to main content
NCBI home page
The British Journal of Cancer. Supplement logoLink to The British Journal of Cancer. Supplement
. 1996 Jul;27:S89–S92.

Chemical modification of normal tissue damage induced by photodynamic therapy.

C P Sigdestad 1, V H Fingar 1, T J Wieman 1, R D Lindberg 1
PMCID: PMC2149989  PMID: 8763855

Abstract

One of the limitations of successful use of photodynamic therapy (PDT) employing porphyrins is the acute and long-term cutaneous photosensitivity. This paper describes results of experiments designed to test the effects of two radiation protective agents (WR-2721, 500 mg kg-1 or WR-3689, 700 mg kg-1) on murine skin damage induced by PDT. C3H mice were shaved and depilated three days prior to injection with the photosensitiser, Photofrin (5 or 10 mg kg-1). Twenty-four hours later, the mice were injected intraperitoneally with a protector 30 min prior to Argon dye laser (630 nm) exposure. The skin response was followed for two weeks post irradiation using an arbitrary response scale. A light dose response as well as a drug dose response was obtained. The results indicate that both protectors reduced the skin response to PDT, however WR-2721 was demonstrated to be the most effective. The effect of the protectors on vascular stasis after PDT was determined using a fluorescein dye exclusion assay. In mice treated with Photofrin (5 mg kg-1), and 630 nm light (180 J cm-2) pretreatment with either WR-2721 or WR-3689 resulted in significant protection of the vascular effects of PDT. These studies document the ability of the phosphorothioate class of radiation protective agents to reduce the effects of light on photosensitized skin. They do so in a drug dose-dependent fashion with maximum protection at the highest drug doses.

Full text

PDF
S89

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bedwell J., Chatlani P. T., MacRobert A. J., Roberts J. E., Barr H., Dillon J., Bown S. G. Enhanced tumour selectivity of photodynamic therapy in the rat colon using a radioprotective agent. Photochem Photobiol. 1991 Jun;53(6):753–756. doi: 10.1111/j.1751-1097.1991.tb09888.x. [DOI] [PubMed] [Google Scholar]
  2. Bellnier D. A., Dougherty T. J. Protection of murine foot tissue and transplantable tumor against Photofrin-II-mediated photodynamic sensitization with WR-2721. J Photochem Photobiol B. 1989 Nov;4(2):219–225. doi: 10.1016/1011-1344(89)80007-7. [DOI] [PubMed] [Google Scholar]
  3. Bugelski P. J., Porter C. W., Dougherty T. J. Autoradiographic distribution of hematoporphyrin derivative in normal and tumor tissue of the mouse. Cancer Res. 1981 Nov;41(11 Pt 1):4606–4612. [PubMed] [Google Scholar]
  4. Dillon J., Kennedy J. C., Pottier R. H., Roberts J. E. In vitro and in vivo protection against phototoxic side effects of photodynamic therapy by radioprotective agents WR-2721 and WR-77913. Photochem Photobiol. 1988 Aug;48(2):235–238. doi: 10.1111/j.1751-1097.1988.tb02815.x. [DOI] [PubMed] [Google Scholar]
  5. Fingar V. H., Henderson B. W. Drug and light dose dependence of photodynamic therapy: a study of tumor and normal tissue response. Photochem Photobiol. 1987 Nov;46(5):837–841. doi: 10.1111/j.1751-1097.1987.tb04856.x. [DOI] [PubMed] [Google Scholar]
  6. Grdina D. J., Nagy B., Hill C. K., Wells R. L., Peraino C. The radioprotector WR1065 reduces radiation-induced mutations at the hypoxanthine-guanine phosphoribosyl transferase locus in V79 cells. Carcinogenesis. 1985 Jun;6(6):929–931. doi: 10.1093/carcin/6.6.929. [DOI] [PubMed] [Google Scholar]
  7. Grdina D. J., Sigdestad C. P. Chemical protection and cell-cycle effects on radiation-induced mutagenesis. Cell Prolif. 1992 Jan;25(1):23–29. doi: 10.1111/j.1365-2184.1992.tb01434.x. [DOI] [PubMed] [Google Scholar]
  8. Hariharan P. V., Courtney J., Eleczko S. Production of hydroxyl radicals in cell systems exposed to haematoporphyrin and red light. Int J Radiat Biol Relat Stud Phys Chem Med. 1980 Jun;37(6):691–694. [PubMed] [Google Scholar]
  9. Henderson B. W., Dougherty T. J. How does photodynamic therapy work? Photochem Photobiol. 1992 Jan;55(1):145–157. doi: 10.1111/j.1751-1097.1992.tb04222.x. [DOI] [PubMed] [Google Scholar]
  10. Henderson B. W., Miller A. C. Effects of scavengers of reactive oxygen and radical species on cell survival following photodynamic treatment in vitro: comparison to ionizing radiation. Radiat Res. 1986 Nov;108(2):196–205. [PubMed] [Google Scholar]
  11. Henderson B. W., Waldow S. M., Mang T. S., Potter W. R., Malone P. B., Dougherty T. J. Tumor destruction and kinetics of tumor cell death in two experimental mouse tumors following photodynamic therapy. Cancer Res. 1985 Feb;45(2):572–576. [PubMed] [Google Scholar]
  12. Milas L., Hunter N., Reid B. O., Thames H. D., Jr Protective effects of S-2-(3-aminopropylamino)ethylphosphorothioic acid against radiation damage of normal tissues and a fibrosarcoma in mice. Cancer Res. 1982 May;42(5):1888–1897. [PubMed] [Google Scholar]
  13. Nagy B., Dale P. J., Grdina D. J. Protection against cis-diamminedichloroplatinum cytotoxicity and mutagenicity in V79 cells by 2-[(aminopropyl)amino]ethanethiol. Cancer Res. 1986 Mar;46(3):1132–1135. [PubMed] [Google Scholar]
  14. Nagy B., Grdina D. J. Protective effects of 2-[(aminopropyl)amino] ethanethiol against bleomycin and nitrogen mustard-induced mutagenicity in V79 cells. Int J Radiat Oncol Biol Phys. 1986 Aug;12(8):1475–1478. doi: 10.1016/0360-3016(86)90197-5. [DOI] [PubMed] [Google Scholar]
  15. Schwartz J. L., Giovanazzi S. M., Karrison T., Jones C., Grdina D. J. 2-[(Aminopropyl)amino] ethanethiol-mediated reductions in 60Co gamma-ray and fission-spectrum neutron-induced chromosome damage in V79 cells. Radiat Res. 1988 Jan;113(1):145–154. [PubMed] [Google Scholar]
  16. Sigdestad C. P., Connor A. M., Sims C. S. Modification of neutron-induced hematopoietic effects by chemical radioprotectors. Int J Radiat Oncol Biol Phys. 1992;22(4):807–811. doi: 10.1016/0360-3016(92)90529-q. [DOI] [PubMed] [Google Scholar]
  17. Weishaupt K. R., Gomer C. J., Dougherty T. J. Identification of singlet oxygen as the cytotoxic agent in photoinactivation of a murine tumor. Cancer Res. 1976 Jul;36(7 Pt 1):2326–2329. [PubMed] [Google Scholar]

Articles from The British Journal of Cancer. Supplement are provided here courtesy of Cancer Research UK

RESOURCES